HBIO (Harvard Bioscience Inc.) Stock Price

Harvard Bioscience supplies equipment for biomedical laboratories. This price chart from GURU.Markets visualizes stable demand for consumables, which provides the company with a steady cash flow. The business minimizes geopolitical risks through global production distribution and localized assembly in the EU and US. A team of scientists and engineers creates cutting-edge instruments, achieving a metric of 9.72.

HBIO - Harvard Bioscience, Inc. Market Chart over the range 07/04/2022 - 11/12/2026

Metric breakdowns and analytics for harvardbioscience.com (HBIO)

- stock quotes and analyst forecast:

Stock Price Harvard Bioscience|HBIO - Fair Value Consensus

- business market valuation indicators:

Market Capitalization Harvard Bioscience Inc.|HBIO - Total Company Value

- book capitalization information:

Book Value per Share Harvard Bioscience|HBIO - Book Valuation of Business|Market Value to Book Value Ratio harvardbioscience.com|HBIO - Company Assets

- debt obligations and liquidity statistics:

- earnings and market ratios statistics:

HBIO - Net Income|Projected Future Earnings Harvard Bioscience|HBIO - P/E Multiple|Future Price to Earnings Harvard Bioscience|HBIO - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Harvard Bioscience Inc.|HBIO - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Harvard Bioscience|HBIO - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months harvardbioscience.com|HBIO - Earnings per share growth this year|Net earnings per share growth forecast for next year Harvard Bioscience

Analysis of all company metrics:Harvard Bioscience

Signature product of harvardbioscience.com

The financial stability of Harvard Bioscience (HBIO) is supported by diversified demand for bio-research equipment from global laboratories, which minimizes market risks. This daily price action, presented via a snapshot of exchange quotes on GURU.Markets, captures the final market consensus on the share price, allowing investors to assess the dynamics of the business's fundamental value through the prism of current market expectations.

Who Harvard Bioscience competes with